“Clinician- and Patient-Reported Outcomes with Tirbanibulin 1% Treatment for Actinic Keratosis in Routine Clinical Practice Across the U.S. (PROAK Study)”, J of Skin, vol. 7, no. 3, pp. 771–787, May 2023, doi: 10.25251/skin.7.3.3.